Table 1:
Characteristics | Patients | % |
---|---|---|
No. of patients | 47 | |
No. of carotid arteries | 49 | |
Sex ratio (women/men) | 27/18; 1.5:1 | |
Median age (yr) (IQR) | 48 (39–56) | |
At least 1 vascular risk factor | 22 | 47% |
High blood pressure | 8 | 17% |
Dyslipidemia | 3 | 6% |
Mellitus diabetes | 0 | 0% |
Smoking | 19 | 40% |
History of autoimmune disease | 8 | 17% |
History of vascular event | 2 | 4% |
Recent history of viral episode | 2 | 4% |
Recent history of cervical chiropractic manipulation | 0 | 0% |
Recent history of cervical trauma | 1 | 2% |
Acute neck tenderness or cervical pain | 47 | 100% |
Affected side (left/right) | 28/21 | |
Bilateral involvement | 2 | 4% |
Median pain intensity (10-point scale) (IQR) | 5 (3–6) | |
Cervical swelling or palpable abnormality over the carotid bifurcation | 6 | 13% |
Enlarged lymph nodes at palpation | 8 | 17% |
Fever | 2 | 4% |
Flu-like symptoms | 1 | 2% |
Neurologic-associated symptoms | 8 | 17% |
No abnormal biologic test findings | 42 | 89% |
Biologic inflammatory syndrome (elevated ESR or CRP) | 3 | 6% |
Positive serum IgM | 2/18 | 11% |
Treatments | 37 | 79% |
Anti-inflammatory treatment | 34 | 72% |
Steroids | 3 | 6% |
Follow-up | 47 | 100% |
Median follow-up duration (days) (IQR) | 163 (88–354) | |
Full clinical recovery (SD) | 47 | 100% |
Mean recovery delay (days) (IQR) | 13 (10–15) | |
Relapse | 9 | 19% |
Median delay before relapse (mo) | 6 | |
Persistence of abnormal laboratory test findings | 0 | 0% |
Note:—ESR indicates erythrocyte sedimentation rate; CRP, C-reactive protein; IgM, immunoglobulin-M; IQR, interquartile range.